PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

Search

Reset

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : O

Records returned : 158 (on 21 Nov 2024 at 16:25:01).

Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
01.09.01
Obeticholic acid
Primary biliary cholangitis
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
R
SA
NHSE
NICE
Important
Dose adjustment and monitoring in pre-existing moderate / severe hepatic impairment. NHSE specialised commissioning - RSFT only.
Obinutuzumab
No Information Returned
Octreotide acetate
No Information Returned
Oestrogens conjugated
No Information Returned
Oestrogens conjugated with bazedoxifene
No Information Returned
Oestrogens conjugated with progestogen
No Information Returned
Ofatumumab
No Information Returned
05.01.12
12.01.01
Ofloxacin
Bacterial infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Oils for the ear
No Information Returned
04.02.01
04.06.00
Olanzapine
Nausea and vomiting (chemotherapy induced)
Red
Formulations :
  • Oro-dispersible
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Un
Important
Off-label use.
04.02.01
04.06.00
Olanzapine
Parkinson's Disease (psychosis)
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Olanzapine embonate
No Information Returned
Olaparib
No Information Returned
02.05.05
Olmesartan medoxomil
Hypertension
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Olmesartan medoxomil/amlodipine
No Information Returned
Olmesartan medoxomil/amlodipine/hydrochlorothiazide
No Information Returned
Olmesartan medoxomil/hydrochlorothiazide
No Information Returned
Olodaterol
No Information Returned
11.04.02
Olopatadine
Allergic conjunctivitis
Green (see narrative)
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe generically.
Sodium cromoglycate 2% or Antazoline with Xylometazoline (Otrivine-Antistin) are the preferred antihistamine/anti-inflammatory eye drops Olopatidine licensed from 3 years of age.
01.05.01
Olsalazine sodium
Inflammatory bowel disease
Non Formulary
Formulations :
  • Capsules
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Licensed in mild ulcerative colitis
Omalizumab
No Information Returned
Omega-3 marine triglycerides
No Information Returned
02.12.00
Omega-3-acid ethyl esters
Raised triglycerides
Red
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribing in Primary Care may continue for existing patients under certain circumstances whilst waiting for specialist review. Please see PAD for detail
01.03.05
Omeprazole
Acid Suppression (Children)
Green
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Preferred
1st line option in children who are able to swallow capsules. Most capsules can also be opened and mixed with water or fruit juice (licensed).
01.03.05
Omeprazole
Acid suppression (Adults)
Green
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Preferred
1st line for patients with no swallowing difficulties.
01.03.05
Omeprazole
Acid Suppression (Children)
Green (see narrative)
Formulations :
  • Dispersible tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Mezzopram is the preferred brand - smaller granule size. Omeprazole MUPS is an alternative. Disperse in water then mix with juice, apple sauce or yoghurt
01.03.05
Omeprazole
Acid Suppression (Children)
Blue
Formulations :
  • Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
R
Important
Only for children under 10kg and/or with a feeding tube less than 8Fr
01.03.05
Omeprazole
Acid Suppression (Children)
Red
Formulations :
  • Powder
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
R
U
Important
Aclomep powder - ASPH NICU only
01.03.05
Omeprazole
Post endoscopy haemorrhage
Red
Formulations :
  • Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Un
01.03.05
Omeprazole
Gastric / Duodenal ulcer
Red
Formulations :
  • Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
ASPH use pantoprazole IV 1st-line
01.03.05
Omeprazole
Zollinger-Ellison syndrome
Red
Formulations :
  • Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
ASPH use pantoprazole IV 1st-line
01.03.05
Omeprazole
Gastric bleed
Red
Formulations :
  • Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
ASPH use pantoprazole IV 1st-line
01.03.05
Omeprazole
Acid suppression (Adults)
Non Formulary
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
Important
Omeprazole or lansoprazole capsules are 1st-line. Pantoprazole or rabeprazole tablets are 2nd-line for patients without swallowing difficulties (suitable for patients that cannot have animal-derived products).
01.03.05
Omeprazole
Acid suppression (Adults)
Non Formulary
Formulations :
  • Oral suspension
  • Oro-dispersible
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
Important
Omeprazole capsules can be opened for patients with swallowing difficulties. Lansoprazole oro-dispersible tablets are 1st-line for patients with enteral feeding tubes
01.03.05
Omeprazole
Acid Suppression (Children)
Non Formulary
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
04.06.00
Ondansetron hydrochloride
Nausea and vomiting (pregnancy)
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
R
Un
Important
2nd line treatment option. Should not be prescribed for longer than 5 days and not recommended in the first trimester.
04.06.00
Ondansetron hydrochloride
Nausea and vomiting (pregnancy)
Green (see narrative)
Formulations :
  • Orodispersible films
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
R
Un
Important
An option in patients with swallowing difficulties. 2nd line treatment option. Should not be prescribed for longer than 5 days and not recommended in the first trimester.
04.06.00
Ondansetron hydrochloride
Nausea and vomiting (chemotherapy induced)
Blue
Formulations :
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Oral solution reserved for use when tablets are not suitable. On request from the specialist / Cancer Centre
04.06.00
Ondansetron hydrochloride
Nausea and vomiting (chemotherapy induced)
Blue
Formulations :
  • Oro-dispersible
  • Orodispersible films
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Orodispersible preparations reserved for use when ordinary tablets are not suitable. On request from the specialist / Cancer Centre
04.06.00
Ondansetron hydrochloride
Nausea and vomiting (chemotherapy induced)
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
04.06.00
Ondansetron hydrochloride
Nausea and vomiting (post operative)
Red
Formulations :
  • Injection
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Oral solution reserved for use when tablets are not suitable.
04.06.00
Ondansetron hydrochloride
Nausea and vomiting (post operative)
Red
Formulations :
  • Oro-dispersible
  • Orodispersible films
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Orodispersible preparations reserved for use when ordinary tablets are not suitable.
04.06.00
Ondansetron hydrochloride
Nausea and vomiting (post operative)
Red
Formulations :
  • Suppositories
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
04.06.00
Ondansetron hydrochloride
Nausea and vomiting
Red
Formulations :
  • Injection
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Un
Important
Non-specific nausea / vomiting. See separate entries for pregnancy, post-operative and chemo-related indications.
Off-label use. Only licensed for post-operative and chemotherapy-induced nausea and vomiting
04.06.00
Ondansetron hydrochloride
Nausea and vomiting
Red
Formulations :
  • Oro-dispersible
  • Orodispersible films
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Un
Important
Non-specific nausea / vomiting. See separate entries for pregnancy, post-operative and chemo-related indications.
Orodispersible preparations reserved for use when ordinary tablets are not suitable.
04.06.00
Ondansetron hydrochloride
Nausea and vomiting (pregnancy)
Non Formulary
Formulations :
  • Oral solution
  • Oro-dispersible
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Orodispersible films are a more cost effective option than oral solution and orodispersible tablets.
04.09.01
Opicapone
Parkinson's disease
Blue
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
NICE
Important
2nd line COMT inhibitor. Entacapone is the locally agreed 1st-line choice
Opium and morphine
No Information Returned
Oral rehydration salts
No Information Returned
Orciprenaline sulfate
No Information Returned
04.05.01
Orlistat
Weight management in adults
Green
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
04.09.02
Orphenadrine hydrochloride
Parkinson's disease
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Oseltamivir phosphate
No Information Returned
Osimertinib
No Information Returned
06.04.01
07.02.01
Ospemifene
Vaginal atrophy
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Initiation in primary care following specialist recommendation. Reserve for severe dryness or when other treatments are ineffective / contraindicated.
Other acid preparations
No Information Returned
Other adsorbent and bulk-forming preparations
No Information Returned
Other alcohol and saline preparations
No Information Returned
Other alcohol, wine and spirit preparations
No Information Returned
Other amino acidandnutritional agent preparations
No Information Returned
Other antacid and simeticone preparations
No Information Returned
Other antidepressant preparations
No Information Returned
Other anti-inflammatory preparations
No Information Returned
Other antiperspirant preparations
No Information Returned
Other antiviral preparations
No Information Returned
Other aromatic inhalation preparations
No Information Returned
Other aural preparations
No Information Returned
Other barrier preparations
No Information Returned
Other base/diluent/suspending agent/stabiliser preparations
No Information Returned
Other bisphosphonate and other preparations
No Information Returned
Other bitter and tonic preparations
No Information Returned
Other calcium supplement preparations
No Information Returned
Other camouflage preparations
No Information Returned
Other chromium preparations
No Information Returned
Other colour, flavour and sweetening preparations
No Information Returned
Other compound vitamin/mineral formulation preparations
No Information Returned
Other concentrated water preparations
No Information Returned
Other cordial/soft drink preparations
No Information Returned
Other desloughing agents
No Information Returned
Other diagnostic agent preparations
No Information Returned
Other diagnostic vaccine preparations
No Information Returned
Other digestive aid preparations
No Information Returned
Other disinfectant,preservative and sterilising preparations
No Information Returned
Other drugs to treat neuropathic pain
No Information Returned
Other dusting powder preparations
No Information Returned
Other eczema preparations
No Information Returned
Other emollient preparations
No Information Returned
Other enzyme preparations 0911020
No Information Returned
Other erectile dysfunction preparations
No Information Returned
Other expectorantand demulcent cough preparations
No Information Returned
Other extract preparations
No Information Returned
Other eye tear/lubricant/astringent preparations
No Information Returned
Other food for special diet preparations
No Information Returned
Other food preparations
No Information Returned
Other gas preparations
No Information Returned
Other health supplement preparations
No Information Returned
Other HIV infection preparations
No Information Returned
Other homeopathic preparations
No Information Returned
Other household and over the counter preparations
No Information Returned
Other hypnotic preparations
No Information Returned
Other immunoglobulin preparations
No Information Returned
Other individually formulated bought in preparations
No Information Returned
Other individually formulated prepared extemp preparations
No Information Returned
Other intravenous nutrition preparations
No Information Returned
Other kelp preparations
No Information Returned
Other lozenge and spray preparations
No Information Returned
Other magnesium preparations
No Information Returned
Other male sex hormone and antagonist preparations
No Information Returned
Other mineral formulation preparations
No Information Returned
Other minor cut and abrasion preparations
No Information Returned
Other miscellaneous topical preparations
No Information Returned
Other mouth wash, gargle and dentifrice preparations
No Information Returned
Other multivitamin preparations
No Information Returned
Other nasal infection preparations
No Information Returned
Other neuromuscularar transmisson preparations
No Information Returned
Other non-opioid analgesic preparations
No Information Returned
Other oil preparations
No Information Returned
Other oral anticoagulant preparations
No Information Returned
Other oral iron preparations
No Information Returned
Other oral ulceration and inflammation preparations
No Information Returned
Other osmotic laxative preparations
No Information Returned
Other otitis external preparations
No Information Returned
Other pancreatin preparations
No Information Returned
Other pantothenic acid preparations
No Information Returned
Other parasiticidal preparations
No Information Returned
Other phosphate supplement preparations
No Information Returned
Other preparations
No Information Returned
Other preparations for biliary disorders
No Information Returned
Other psoriasis preparations
No Information Returned
Other purified water preparations
No Information Returned
Other riboflavine (B2) preparations
No Information Returned
Other rubefacient and topical antirheumatic preparations
No Information Returned
Other screening and monitoring agent preparations
No Information Returned
Other selenium preparations
No Information Returned
Other shampoo and scalp preparations
No Information Returned
Other single substance preparations
No Information Returned
Other soothing haemorrhoidal preparations
No Information Returned
Other stimulant laxative preparations
No Information Returned
Other sunscreening preparations
No Information Returned
Other syrup preparations
No Information Returned
01.03.00
Other test for helicobacter pylori preparations
Helicobacter pylori
N/A
Formulations :
  • Test kit
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
SASH / East Surrey Place only - through the LCS
Other tincture preparations
No Information Returned
Other toiletry preparations
No Information Returned
Other topical anaesthetic and antipruritic preparations
No Information Returned
Other topical circulatory preparations
No Information Returned
Other topical corticosteroid preparations
No Information Returned
Other topical nasal decongestant preparations
No Information Returned
Other topical only antibacterial preparations
No Information Returned
Other treatment of dry mouth preparations
No Information Returned
Other urological pain preparations
No Information Returned
Other vaginal/vulva changes preparations
No Information Returned
Other vehicle and emulsifying agent preparations
No Information Returned
Other vitamin A preparations 0906011
No Information Returned
Other vitamin B compound preparations
No Information Returned
Other vitamin B preparations
No Information Returned
Other vitamin C (Ascorbic acid) preparations
No Information Returned
Other vitamin C preparations
No Information Returned
Other vitamin D preparations
No Information Returned
Other vitamin E preparations 0906050
No Information Returned
Other x-ray contrast media preparations
No Information Returned
Other zinc preparations
No Information Returned
Oxaliplatin
No Information Returned
Oxandrolone
No Information Returned
Oxazepam
No Information Returned
04.08.01
Oxcarbazepine
Epilepsy
Blue
Formulations :
  • Oral suspension
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Oxitriptan
No Information Returned
Oxitropium bromide
No Information Returned
Oxprenolol hydrochloride
No Information Returned
11.07.00
Oxybuprocaine hydrochloride
Local anaesthesia (eye)
Red
Formulations :
  • Eye drops (preservative free, unit dose)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
0.4% preservative free eye drops
07.04.02
Oxybutynin
Overactive bladder (adults)
Green (see narrative)
Formulations :
  • Patches
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
R
Important
Solifenacin 1mg/ml oral SUSPENSION is preferred for patients with swallowing difficulties. Oxybutynin patches are reserved for patients where an oral formulation is not suitable
07.04.02
Oxybutynin
Overactive bladder (adults)
N/A
Formulations :
  • Intravesical
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD2
07.04.02
Oxybutynin
Overactive bladder (adults)
Non Formulary
Formulations :
  • Modified release tablets
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
Important
Switch to solifenacin recommended (if appropriate).
Oxybutynin hydrochloride
No Information Returned
04.07.02
Oxycodone
Pain
Green (see narrative)
Formulations :
  • Capsules
  • Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
CD
Important
For patients unable to tolerate / poor response to morphine. Modified-release preparations to be prescribed by brand
04.07.02
Oxycodone
Pain
Green (see narrative)
Formulations :
  • Modified release tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
CD
Important
For use in patients where morphine sulfate is not suitable / not tolerated. Modified-release preparations to be prescribed by brand
04.07.02
Oxycodone
Pain
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
CD
Important
Alternative for patients unable to tolerate / poor response to morphine. Care with dose conversion.
Oxycodone hydrochloride
No Information Returned
Oxycodone hydrochloride/naloxone hydrochloride
No Information Returned
04.07.02
Oxycodone with naloxone
Pain
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
CD
04.07.02
Oxycodone with naloxone
Restless Leg Syndrome
Non Formulary
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Oxymetazoline hydrochloride
No Information Returned
Oxymetholone
No Information Returned
Oxypertine
No Information Returned
05.01.03
Oxytetracycline
Rosacea
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation
07.01.01
Oxytocin
Induction of labour
Red
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
 

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq
BlueTeq form to be completed
NICE
NICE

Traffic Light Status Key

Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Black
Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.
Amber Star
Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)
See Below
Please add a description.
N/A
Please add a description.
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green - Black
Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.
See narrative
See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)
Do not initiate in new patients
These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More